Literature DB >> 11159042

Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.

K A King1, C Hu, M M Rodriguez, R Romaguera, X Jiang, G Piedimonte.   

Abstract

Respiratory syncytial virus (RSV) infection in adult rats causes exaggerated inflammation after sensory nerve stimulation in the extrapulmonary, but not in the intrapulmonary airways. The goal of this study was to analyze neurogenic inflammation in weanling F-344 rats infected with RSV 18 +/- 2 d after birth. Five days after RSV inoculation, the extravasation of Evans blue-labeled albumin after nerve stimulation was significantly greater in the intrapulmonary airways of RSV-infected weanling rats than in pathogen-free control rats. In contrast, no difference was found in the extrapulmonary airways. The level of messenger RNA (mRNA) encoding the substance P (SP) receptor (neurokinin 1 [NK1]) increased fourfold in RSV-infected lungs, whereas mRNA encoding the VIPR1 receptor for the antiinflammatory vasoactive intestinal peptide (VIP) increased to a much lesser degree. mRNAs encoding the other neurokinin (NK2) and VIP (VIPR2) receptors were not affected by the virus. Selective inhibition of the NK1 receptor abolished neurogenic inflammation in RSV-infected intrapulmonary airways. Also, neurogenic inflammation and NK1 receptor upregulation in infected lungs were inhibited by prophylaxis with a monoclonal antibody against RSV. These data suggest that RSV lower respiratory tract infection makes the intrapulmonary airways of young rats abnormally susceptible to the proinflammatory effects of SP by selectively upregulating the expression of NK1 receptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11159042     DOI: 10.1165/ajrcmb.24.2.4264

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  24 in total

Review 1.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

2.  Neurotrophic and neuroimmune responses to early-life Pseudomonas aeruginosa infection in rat lungs.

Authors:  Silvia Cardenas; Mario Scuri; Lennie Samsell; Barbara Ducatman; Pablo Bejarano; Alexander Auais; Melissa Doud; Kalai Mathee; Giovanni Piedimonte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-11       Impact factor: 5.464

Review 3.  Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity.

Authors:  Paul M Brown; Dana L Schneeberger; Giovanni Piedimonte
Journal:  Paediatr Respir Rev       Date:  2015-05-23       Impact factor: 2.726

4.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

Review 5.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

6.  Identification of gene biomarkers for respiratory syncytial virus infection in a bronchial epithelial cell line.

Authors:  Yuh-Chin T Huang; Zhuowei Li; Xhevahire Hyseni; Michael Schmitt; Robert B Devlin; Edward D Karoly; Joleen M Soukup
Journal:  Genomic Med       Date:  2009-05-15

7.  Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infection.

Authors:  Lia M Haynes; Joelyn Tonkin; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 8.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

9.  Neurotrophins and tonsillar hypertrophy in children with obstructive sleep apnea.

Authors:  Aviv D Goldbart; Edward Mager; Maria C Veling; Julie L Goldman; Leila Kheirandish-Gozal; Laura D Serpero; Giovanni Piedimonte; David Gozal
Journal:  Pediatr Res       Date:  2007-10       Impact factor: 3.756

10.  Combined effects of chronic nicotine and acute virus exposure on neurotrophin expression in rat lung.

Authors:  Fernando Urrego; Mario Scuri; Alexander Auais; Lida Mohtasham; Giovanni Piedimonte
Journal:  Pediatr Pulmonol       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.